The Frost and Sullivan decision process involved three major steps
Vetter, a global CDMO, has been awarded the Frost & Sullivan’s 2021 Global Customer Value Leadership Award in the aseptic fill & finish market. The award, presented annually by the growth and consulting firm, focuses on business and customer impact and takes the current situation into account as well as trends in the market.
The decision process involved three major steps. First, the firm examined service providers from the pharmaceutical and biotech industry across ten criteria including financial performance, operational efficiency, growth potential, price/performance value as well as customer service experience. Second, an interview was done with a senior management representative based on a qualitative and quantitative measurement of the criteria. Finally, a nomination compendium was created and reviewed by Frost & Sullivan’s Best Practices Recognition committee.
Vetter was recognised for providing high customer value, in particular, the company’s best practices in collaboration with global customers. The committee further pointed to the CDMO's ability to provide support from the early development phase of drugs through regulatory approval and market supply worldwide.
Frost & Sullivan’s Industry Expert Surbhi Gupta said: “Vetter is renowned for its quality, innovation and loyalty as a strategic partner for pharmaceutical and biotech clients. The company offers end-to-end development and manufacturing services for variable batch sizes and drug-delivery systems, backed by flexible, scalable, and reproducible processes. Thus, we believe Vetter to be a well-qualified recipient of this award.”
Vetter MD Peter Soelkner said: “We always make our best efforts to provide customers with state-of-the-art services that help them improve the quality of life for patients worldwide. Our contributions to those mutual partnerships are intended to help secure their success in the global marketplace.”